Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  36 نتائج ل ""Phase III as Topic""

فلترة النتائج

Publisher : blackwell science
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).

Subjects: Conservative Treatment* ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology

  • Source: BJU international [BJU Int] 2024 Jun; Vol. 133 (6), pp. 680-689. Date of Electronic Publication: 2024 Mar 12.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Comparative severe dermatologic toxicities of immune checkpoint inhibitors in malignant melanoma: A systematic review and network meta-analysis.

  • Authors : Mao YT; Department of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Wang Y

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Ipilimumab*/Ipilimumab*/Ipilimumab*/adverse effects ; Ipilimumab*/Ipilimumab*/Ipilimumab*/administration & dosage

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Apr; Vol. 23 (4), pp. 1165-1177. Date of Electronic Publication: 2023 Nov 27.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia.

Subjects: Afibrinogenemia*/Afibrinogenemia*/Afibrinogenemia*/complications ; Afibrinogenemia*/Afibrinogenemia*/Afibrinogenemia*/drug therapy ; Hemostatics*/Hemostatics*/Hemostatics*/therapeutic use

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Nov; Vol. 28 (6), pp. 1022-1032. Date of Electronic Publication: 2022 Aug 04.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Epothilones and the next generation of phase III trials for prostate cancer.

  • Authors : Bhandari MS; Division of Hematology Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Hussain M

Subjects: Clinical Trials, Phase III as Topic*; Epothilones/Epothilones/Epothilones/*therapeutic use ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*drug therapy

  • Source: BJU international [BJU Int] 2005 Aug; Vol. 96 (3), pp. 296-302.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency.

  • Authors : Payne J; Department of Paediatric Haematology, Sheffield Children's NHS Foundation Trust, Sheffield, UK.; Batsuli G

Subjects: Factor X*/Factor X*/Factor X*/adverse effects ; Factor X Deficiency*/Factor X Deficiency*/Factor X Deficiency*/drug therapy; Adolescent

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. 523-531. Date of Electronic Publication: 2022 May 02.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?

  • Authors : Gupta AK; Mediprobe Research Inc., London, ON, Canada.; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Subjects: Alopecia* ; Finasteride*/Finasteride*/Finasteride*/adverse effects; Administration, Topical

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2022 May; Vol. 21 (5), pp. 1841-1848. Date of Electronic Publication: 2022 Mar 14.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer.

Subjects: Prostatectomy*; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*pathology; Aged

  • Source: BJU international [BJU Int] 2017 Nov; Vol. 120 (5B), pp. E45-E51. Date of Electronic Publication: 2017 Jan 19.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies.

  • Authors : Oelke M; Department of Urology, Hannover Medical School, Hannover, Germany.; Wagg A

Subjects: Lower Urinary Tract Symptoms/Lower Urinary Tract Symptoms/Lower Urinary Tract Symptoms/*drug therapy ; Lower Urinary Tract Symptoms/Lower Urinary Tract Symptoms/Lower Urinary Tract Symptoms/*etiology ; Phosphodiesterase 5 Inhibitors/Phosphodiesterase 5 Inhibitors/Phosphodiesterase 5 Inhibitors/*administration & dosage

  • Source: BJU international [BJU Int] 2017 May; Vol. 119 (5), pp. 793-803. Date of Electronic Publication: 2017 Jan 22.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Review

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.

  • Authors : Hayne D; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.; University of Western Australia Medical School, Crawley, WA, Australia.

Subjects: BCG Vaccine/BCG Vaccine/BCG Vaccine/*administration & dosage ; Mitomycin/Mitomycin/Mitomycin/*administration & dosage ; Urinary Bladder Neoplasms/Urinary Bladder Neoplasms/Urinary Bladder Neoplasms/*drug therapy

  • Source: BJU international [BJU Int] 2017 May; Vol. 119 Suppl 5, pp. 55-57.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia

Subjects: Science & Technology; Life Sciences & Biomedicine; Endocrinology & Metabolism

  • Source: ISSN:0742-3071 ; ISSN:1464-5491 ; Diabetic Medicine, vol. 33 (4), (478-487.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  36 نتائج ل ""Phase III as Topic""